Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by chronic inflammation of the synovium and progressive joint damage. Fibroblast-like synoviocytes (FLSs) exhibit excessive proliferative and aggressive phenotypes and play a major role in the pathophysiology of RA. Previous studies have confirmed the pathologic role of L-selectin in cell adhesion and migration. In rheumatoid arthritis models, L-selectin regulates leukocyte homing, which leads to joint inflammation. Moreover, in L-selectin knockout mice, there is a reduction in joint inflammation. However, the associations of L-selectin with FLSs in RA remain unclear. This study aims to reveal the effect of L-selectin on RA-FLSs and to investigate the molecular mechanism of L-selectin in RA. Our findings indicated that L-selectin was significantly expressed in RA synovial tissues and RA-FLSs. L-selectin silencing reduced RA-FLSs migration and invasion and attenuated the secretion of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in vitro. Moreover, investigations into mechanisms revealed that L-selectin activated the nuclear factor kappa-B (NF-κB) signaling pathway while blocking this signaling pathway could compromise the effects of L-selectin. Finally, in vivo experiments with a collagen-induced arthritis rat model revealed that silencing L-selectin alleviated inflammatory infiltration of the synovium and cartilage destruction, and validated the NF-κB signaling pathways findings observed in vitro. In summary, we show that L-selectin enhances the migration and invasion of RA-FLSs through the activation of NF-κB signaling pathways, ultimately worsening the progression of RA.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10753-025-02242-3DOI Listing

Publication Analysis

Top Keywords

l-selectin
13
migration invasion
12
rheumatoid arthritis
12
signaling pathway
12
nf-κb signaling
12
fibroblast-like synoviocytes
8
joint inflammation
8
signaling pathways
8
signaling
5
l-selectin promotes
4

Similar Publications

Acute respiratory distress syndrome (ARDS) is characterized by excessive neutrophil-driven inflammation and remains a leading cause of mortality in critical care. Leukotriene-modifying agents, such as montelukast (a CysLTR1 antagonist) and zileuton (a 5-lipoxygenase inhibitor), are approved for chronic inflammatory lung diseases, but their role in ARDS is unclear. We investigated the effects of montelukast and zileuton in a murine model of lipopolysaccharide (LPS)-induced ARDS, supported by in vitro assays using human neutrophils.

View Article and Find Full Text PDF

Reconstitution of the T cell compartment is essential in the treatment of several immune disorders. Similarly, individuals with hematological malignancies undergoing allogeneic hematopoietic stem cell transplantation experience prolonged T cell deficiencies, which increase the risk of infections and relapses. Various strategies for addressing T cell deficiencies are based on adoptive T cell therapies.

View Article and Find Full Text PDF

Neutrophil cell surface receptor dynamics following trauma: a systematic review.

Eur J Trauma Emerg Surg

August 2025

Department of Traumatology, University Hospital Zurich, University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Purpose: Neutrophils are essential effector cells in the immune response to traumatic injury. Although changes in receptor expression over time have been described in the literature, effective monitoring strategies are still lacking. This systematic review aims to identify reported neutrophil cell surface receptor dynamics after trauma and to determine the post-traumatic neutrophil signature over time, forming the basis for future immunomonitoring.

View Article and Find Full Text PDF

Background: Skeletal muscle ischemia-reperfusion injury (IRI) is a significant concern in various clinical settings. Oxidative stress and neutrophil infiltration play central roles in its pathophysiology. However, clinicians have very few therapeutic options for the prevention and treatment of IRI.

View Article and Find Full Text PDF